7 апр. 2024 г. · We conducted a trial (Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction [REDUCE-AMI]) to investigate ...

7 апр. 2024 г. · The REDUCE-AMI trial showed that in patients with AMI and preserved LVEF, beta-blockade with metoprolol or bisoprolol was not associated with decreased all- ...

7 апр. 2024 г. · Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial ...

12 апр. 2024 г. · A large, randomized control trial that evaluated the efficacy and safety of long-term selective oral beta blockade (sustained release metoprolol or bisoprolol) Evidence before this study · Study design · Study patients

2 февр. 2023 г. · The aim of the randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI) trial is to determine whether long-term ...

16 мая 2024 г. · This trial provides some initial evidence that beta-blockers might not be indicated post-MI if there is preserved ejection fraction on a post-MI echocardiogram.

7 апр. 2024 г. · 24. REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta ...

7 апр. 2024 г. · (UPDATED) The latest study to undermine the role of these long-standing agents suggests their use harkens back to a bygone era.

7 апр. 2024 г. · The parallel-group, open-label trial, conducted from September 2017 through May 2023 at 45 centers across Sweden, Estonia and New Zealand ...

15 апр. 2024 г. · Several other ongoing trials will shed further light on the role of beta-blockers in patients post-MI with LVEF >40%, including: ABYSS (n=3700, ...